JHOP (@jhoponline) 's Twitter Profile
JHOP

@jhoponline

Journal of Hematology Oncology Pharmacy, the peer-reviewed forum for oncology pharmacy practice. A @TheLynxGroup journal and the official publication of @HOPArx

ID: 1382684987401601026

linkhttp://jhoponline.com/ calendar_today15-04-2021 13:19:40

234 Tweet

261 Followers

93 Following

JHOP (@jhoponline) 's Twitter Profile Photo
JHOP
@jhoponline

3 years ago

A clinical trial compared the benefits of the PD-1 inhibitor pembrolizumab plus chemotherapy versus placebo plus chemotherapy in treatment-naïve patients with early-stage, triple-negative breast cancer (TNBC). bit.ly/3NfMbcO

A clinical trial compared the benefits of the PD-1 inhibitor pembrolizumab plus chemotherapy versus placebo plus chemotherapy in treatment-naïve patients with early-stage, triple-negative breast cancer (TNBC). bit.ly/3NfMbcO